THERALASE® TECHNOLOGIES
Stock Information
Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the
- TSX Venture Exchange (TLT: TSXV)
- TLTFF: OTCQB
Data last updated on February 8, 2024
Number of common shares outstanding
Shares Outstanding: 228,460,858
Warrants: 80,524,017
Stock Options: 18,510,000
For Investor Relations please contact: Investor Information Theralase®